emerging-tech-investing Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study 20 October 2025
emerging-tech-investing Sona Nanotech To Host Investor Webinar To Discuss Clinical Study 17 October 2025
